Success Metrics

Clinical Success Rate
100.0%

Based on 7 completed trials

Completion Rate
100%(7/7)
Active Trials
2(14%)
Results Posted
14%(1 trials)

Phase Distribution

Ph phase_2
5
36%
Ph phase_3
1
7%
Ph not_applicable
8
57%

Phase Distribution

0

Early Stage

5

Mid Stage

1

Late Stage

Phase Distribution14 total trials
Phase 2Efficacy & side effects
5(35.7%)
Phase 3Large-scale testing
1(7.1%)
N/ANon-phased studies
8(57.1%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

87.5%

7 of 8 finished

Non-Completion Rate

12.5%

1 ended early

Currently Active

2

trials recruiting

Total Trials

14

all time

Status Distribution
Active(2)
Completed(7)
Terminated(1)
Other(4)

Detailed Status

Completed7
unknown4
Recruiting2
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
14
Active
2
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 25 (35.7%)
Phase 31 (7.1%)
N/A8 (57.1%)

Trials by Status

completed750%
withdrawn17%
unknown429%
recruiting214%

Recent Activity

Clinical Trials (14)

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
14